People

Kevin Fitzgerald

Director of Ovid Therapeutics and RNA interference drug discovery scientist associated with Alnylam Pharmaceuticals. Joined Alnylam in 2005 after Bristol Myers Squibb and contributed to development of siRNA delivery approaches. Distinct from Kevin FitzGerald, the Epsilogen executive already recorded in Adex.